EASD 2022 Semaglutide 1st and 2nd Oral Slides

HbA1c and weight changes with semaglutide at 6- and 12-months post commencement: Updated results from the ABCD Semaglutide audit.

Authors:

BCT Field, TSJ Crabtree, K Adamson, D Barnes, S Sivappriyan, A. Bickerton, A Gallagher, IW Gallen, I Idris, REJ Ryder;  on behalf of ABCD Semaglutide audit contributors

Discipline

Diabetes
Resource taxonomy
Audit Slides
Clinical taxonomy
Treatments for diabetes Type 2 diabetes mellitus
Listing status
Current

ABCD Corporate Pharma Sponsors

Gold

  • AstraZeneca UK
  • Boehringer Ingelheim and Lilly Alliance
  • Eli Lilly and Company

Silver

  • A Menarini Farmaceutica Internazionale SRL
  • Sanofi

ABCD Corporate Pump & Device Sponsors

Gold

  • Abbott
  • Dexcom
  • Ypsomed Ltd

Silver

  • Air Liquide Healthcare Ltd
  • Insulet International
  • Medtronic Limited

Contact

Address for correspondence: 
ABCD (Diabetes Care) Ltd, 483 Green Lanes, London, N13 4BS

Telephone: 01675 477602
Email: info@abcd.care

Follow Us

ABCD (Diabetes Care) is a company limited by shares in England and Wales under company number 7270377, whose registered address is 3rd Floor, 56 Wellington Street. Leeds, LS1 2EE  Diabetes Care Trust (ABCD) is a registered charity number 1139057, a company limited by guarantee in England and Wales under company number 74248361,whose registered address is 3rd Floor, 56 Wellington Street. Leeds, LS1 2EE . ABCD (Diabetes Care) Ltd is a wholly owned subsidiary of the Diabetes Care Trust (ABCD) Ltd